Gilead Gets PTAB To Wipe Out University's Antiviral IP Claims
The Patent Trial and Appeal Board has thrown out more than two dozen claims in a University of Minnesota patent covering a compound with antiviral and anti-cancer properties, handing a win...To view the full article, register now.
Already a subscriber? Click here to view full article